Translate page

3

The 2025 iCMLf South Asia Regional Discussion Group (RDG) series offered a powerful window into the evolving realities of CML care across the region.

Held across three Zoom-based sessions between April and July, the program convened 190 CML physicians from India, Pakistan, Nepal, Sri Lanka, Bangladesh, and further afield, alongside international experts, to discuss dose reduction and treatment-free remission (TFR), TKI sequencing strategies, and difficult real-world cases.

But beyond the individual session topics, a deeper story emerged - of clinicians consistently navigating limited evidence or testing to guide decisions, infrastructure gaps, and treatment constraints with ingenuity, collaboration, and commitment to best practice.

Here are three key themes that surfaced across the series:

Collage Stokłosa HochhausJune 2025 - Join us for our next iCMLf Conversation on Tuesday, July 22nd 2025 at 14.00 CEST where international CML experts will review and discuss the most important biological and clinical updates presented during EHA2025.

Whether you attended EHA2025 or not, this session will summarise CML highlights into the most important takeaways for the CML community.

📅 Date: Tuesday, July 22nd
🕑 Time: 14:00 CEST
🖥️ Format: Live webinar on Zoom

Logo EHA 2025

We're bringing you daily updates from the CML sessions at EHA2025 Congress. Check back each day for updates on the day's sessions.

Stay tuned for more coverage of CML @ EHA2025 over the next few days!

Logo EHA 2025

May 2025 - The countdown to the European Hematology Association (EHA) 2025 Congress has begun! From June 12-15 in Milan, the international CML community will come together to explore groundbreaking developments in CML biology, therapy, and patient care. 

To make sure you don’t miss any important sessions and discussions, we have compiled an overview of CML related sessions at EHA2025 Congress for you.

Read on for more information...

3

In 1999, the first tyrosine kinase inhibitor (TKI) transformed the treatment of chronic myeloid leukemia - and changed the course of cancer care worldwide.

This year, we mark 25 years since that breakthrough. It’s more than a scientific milestone - it’s a story of lives extended and a global community working to ensure access to treatment for all.

To honor this anniversary, the iCMLf is sharing reflections, resources, and real-world impact from across our network:

3

Since 2020, Isabella has been raising money for the iCMLf in honor of her mum, who was diagnosed with CML that year. Over the years, she’s run fun runs, rallied her school community, and inspired people around the world with her determination and heart.

And she’s not done yet.